527
Participants
Start Date
October 1, 2006
Primary Completion Date
April 3, 2014
Study Completion Date
April 3, 2014
Cyclosporine & Cellcept
Dose and frequency determined as usual by transplant physicians. The drugs are not experimental drugs. The study is looking at reducing negative side effects of some of the drugs.
Prograf & Cellcept
Dose and frequency determined as usual by transplant physicians. The drugs are not experimental drugs. The study is looking at reducing negative side effects of some of the drugs.
Low Dose CNI (Cyclosporine or FK) and Cellcept
Dose and frequency determined as usual by transplant physicians. The drugs are not experimental drugs. The study is looking at reducing negative side effects of some of the drugs.
Rapamune and Cellcept
Dose and frequency determined as usual by transplant physicians. The drugs are not experimental drugs. The study is looking at reducing negative side effects of some of the drugs.
University of Minnesota, Minneapolis
Roche Pharma AG
INDUSTRY
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Genzyme, a Sanofi Company
INDUSTRY
University of Minnesota
OTHER